Santen Pharmaceutical Co., Ltd. (TYO:4536)

Santen Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Santen Pharmaceutical had annual revenue of 291.62B JPY, down -2.79%. Santen Pharmaceutical had revenue of 80.86B in the quarter ending March 31, 2026, with 4.70% growth.

• Revenue: 291.62B
• Revenue Growth: -2.79%
• P/S Ratio: 2.11
• Revenue / Employee: 75.77M
• Employees: 3,849
• Market Cap: 616.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	291.62B	-8.38B	-2.79%
Mar 31, 2025	300.00B	-1.96B	-0.65%
Mar 31, 2024	301.97B	22.93B	8.22%
Mar 31, 2023	279.04B	12.78B	4.80%
Mar 31, 2022	266.26B	16.65B	6.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error